Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
134.93
-12.07 (-8.21%)
At close: Jun 2, 2026, 4:00 PM EDT
137.62
+2.69 (1.99%)
After-hours: Jun 2, 2026, 7:54 PM EDT

Belite Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
-352.9331.6888.1642.0917.34
Short-Term Investments
-139.49113.47---
Cash & Short-Term Investments
-492.42145.1588.1642.0917.34
Cash Growth
-239.25%64.65%109.45%142.67%-32.30%
Other Receivables
-0.70.580.840-
Total Trade Receivables
-0.70.580.840-
Other Current Assets
-1.151.350.950.720.09
Total Current Assets
521.86494.27147.0789.9442.8117.43
Net Property, Plant & Equipment
-0.780.971.31.350.09
Other Intangible Assets
-0.020.03---
Long-Term Investments
289.41566.455.06---
Other Long-Term Assets
-5.324.063.40.120.82
Total Assets
811.27780.56152.1394.6444.2718.35
Accrued Expenses
-9.645.763.331.911.56
Current Portion of Leases
-0.240.280.310.2-
Other Current Liabilities
-0.010.01--0.07
Total Current Liabilities
-9.886.053.632.11.64
Long-Term Leases
-0.190.260.580.67-
Total Long-Term Liabilities
-0.190.260.580.67-
Total Liabilities
15.4810.076.314.212.771.64
Common Stock
-00000
Additional Paid-in Capital
-956.28254.13162.3181.7612.33
Accumulated Other Comprehensive Income
--0.54-0.66-0.37-0.39-0.2
Retained Earnings
--185.26-107.65-71.5-39.87-27.22
Total Common Shareholders' Equity
795.79770.49145.8290.4341.5-15.09
Minority Interest
-----31.81
Shareholders' Equity
795.79770.49145.8290.4341.516.71
Total Liabilities & Equity
811.27780.56152.1394.6444.2718.35
Total Debt
-0.430.540.890.870
Net Cash (Debt)
-491.99144.6187.2741.2217.34
Net Cash Growth
-240.22%65.70%111.71%137.68%-32.30%
Net Cash Per Share
-14.674.743.282.061.81
Book Value
795.79770.49145.8290.4341.5-15.09
Book Value Per Share
22.4322.974.783.402.08-1.58
Tangible Book Value
795.79770.47145.7990.4341.5-15.09
Tangible Book Value Per Share
22.4322.974.773.402.08-1.58
SEC Filings: 10-K · 10-Q